Volume 7 Issue 142
Published - 14:00 UTC 08:00 EST 22-May-2005 
Next Update - 14:00 UTC 08:00 EST 23-May-2005

Editor: Susan K. Boyer, RN
All rights reserved.

We subscribe to the HONcode principles. Verify here.



Biomarkers for interstitial cystitis identified, could lead to the first test

University of Pittsburgh researchers have isolated two biomarkers for interstitial cystitis (IC), a chronic and painful pelvic disease for which there currently is no test. The discovery of these biomarkers could lead to a definitive test for IC and have the potential to lead to new therapies. Results of two studies are being presented today at the annual meeting of the American Urological Association (AUA) in San Antonio, and are published in abstracts 69 and 80 of the AUA proceedings. more  

Lack of coherent cloning policies reflects polarized debate, limited understanding, study says

The confusing welter of state laws regarding human cloning for reproductive purposes and for research uses reflects a national political impasse on regulating cloning, according to a new report by The Genetics & Public Policy Center, a project of The Pew Charitable Trusts and Johns Hopkins University. This lack of a national consensus comes at a time when rapid advances in cloning technology make crafting broader public policy increasingly urgent, the report notes. "While human cloning technology is still in its infancy, the science is outpacing the public's understanding and the formulation of coherent public policy," it warns. more

Research marks giant step in potential of using stem cells to treat human disorders

Research from the Republic of Korea's Seoul National University published in this week's edition of Science represents a major advance in the science of using stem cells to repair damage caused by human disease and injury, according to Gerald Schatten, Ph.D., professor and vice chair of research development in the department of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh School of Medicine and a co-author on the Korean study. more  

Long-term consequences of childhood sexual abuse by gender of victim

Children of both genders are frequently victims of sexual abuse, and the long-term consequences are nearly identical in men and women, according to a broad-based new report in the June 2005 issue of American Journal of Preventive Medicine. more

New way of fighting antibiotic resistance demonstrated by Scripps scientists  

A team of scientists at The Scripps Research Institute and the University of Wisconsin have demonstrated a new way of fighting antibiotic resistance: by stopping evolution. more

New method of administering anti-cancer drug may be more effective, safer 

A novel way of administering an anti-cancer drug to bone-marrow transplant patients using continuous infusion may be more effective and safer than the method currently used, new study findings indicate. more

New treatment option for small bowel bacteria overgrowth (SBBO)

Researchers at the University of Pennsylvania School of Medicine have identified a new drug treatment option for small bowel bacteria overgrowth (SBBO) -- a condition such as Crohn's disease -- which prevents the body from absorbing enough nutrients from the small intestines; and pouchitis, an inflammation of an internal pouch created in patients who have had a section of colon removed. Both conditions are commonly treated with antibiotics. However, use is often limited due to adverse reactions, including nausea, anorexia, peripheral neuropathy, tendonitis, and drug interactions. Gary Lichtenstein, MD, Professor of Medicine and Director, Center for Inflammatory Irritable Bowel Diseases in the Division of Gastroenterology at the Hospital of the University of Pennsylvania, presented his findings today at the annual Digestive Disease Week meeting. more


Clone Confusion